SKI Market

Indian Indices

Nifty

25,959.50 -108.65
(-0.42%)

Sensex

84,900.71 -331.21
( -0.39%)

Bank Nifty

58,835.35 -32.35
( -0.05%)

Nifty IT

37,037.95 152.60
( 0.41%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

203.3941378

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

80.43

22667.85

EPS(TTM)

Face Value()

Div & Yield %

20.69

0.44

Back

ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter

Nov 14,2025

Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	790.15	738.95	7
OPM %	36.48	35.80	-
PBDT	241.75	209.59	15
PBT	172.67	129.11	34
NP	120.19	91.59	31

25,959.50 -108.65 (-0.42%)

84,900.71 -331.21 ( -0.39%)

58,835.35 -32.35 ( -0.05%)

37,037.95 152.60 ( 0.41%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)